NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Syndeio Biosciences

Syndeio Biosciences

Private
Indianapolis, IndianaHealthcare & Life Scienceshttps://www.syndeio.bio/

Last Round

VC Round

May 27, 2025

Total Funding Raised

$15M

Company Overview

Syndeio Biosciences is a biotechnology company developing precision neurotherapeutics to restore and enhance synaptic health in CNS disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

synthetic biologydrug discoverybiotechnologybiological engineeringtherapeutic developmentbiotechprecision medicinebiomarker analyticsclinical developmentdrug pipelinetranslational researchr&d partnershipssynapse-targeted therapypharma r&d

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Syndeio Biosciences Comps

Public and private peers based on sector, stage, and business model.

Syndeio Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Syndeio Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 27, 2025
VC RoundOct 5, 2022
Convertible DebtDec 9, 2021

Key People

Founding team and executive leadership

Michael G. McCully

Co-Founder, President Chief Operating Officer

Founding Team

Syndeio Biosciences Investors

Notable investors and investment history

Syndeio Biosciences investors
InvestorRounds
Luson BioVenturesVC Round
InnovivaVC Round, Convertible Debt
Catalio Capital ManagementVC Round
Palo SantoVC Round
PagodaTree PartnersVC Round
Merck Capital VenturesVC Round
Evolution VC PartnersVC Round

Syndeio Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Syndeio Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Syndeio Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersIndianapolis, Indiana
Employee Range23
Year Founded2018
Last FundingMay 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.